Partners

  • Philips Healthcare Incubator – facilitating disease prevention, diagnosis, treatment, and monitoring
  • Lipomics – (acquired by Tethys, 2008) advancing personalized medicine through the advanced diagnosis and treatment of metabolic disease
  • Pangene – genomics-based company with full capabilities for drug development and genomic services
  • Oncomethylome Sciences - developing tests for early cancer detection and to support personalized medicine treatment decisions
  • Integrated Medicines – alternative medicine approaches
  • Enterprise Analysis – consulting, research, and business development services for healthcare and life sciences companies
  • BD – promoting personalized medicine by serving healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry
  • PathwayDX – (acquired by Quest Diagnostics, 2008) biomarker development, testing, and commercialization for the next generation of clinical diagnostics
  • Nanosphere – develops, manufactures, and markets an advanced molecular diagnostics platform for direct genomic and ultra-sensitive protein detection
  • Innovalyst – helping companies shape their business strategy, catalyze the development of innovations, and accelerate commercial success
  • Clear Point Health – helps healthcare companies develop sound strategies and find optimal solutions specifically customized to the demands and culture of the industry
  • Scintellix – biomedical consultancy that untangles the complex problems that prevent individuals, companies and institutions from achieving their goals
  • Personalized Medicine Coalition – non-profit group that works to advance the understanding and adoption of personalized medicine for the ultimate benefit of patients